Results 101 to 110 of about 1,449,698 (192)

Acupuncture for polycystic ovarian syndrome (protocol)

, 2009
To assess the effectiveness and safety of acupuncture treatment for subfertile women with polycystic ovarian syndrome (PCOS)
Chi Lim (3513470), Jianping Liu (182740), Charlie Xue (8797853), Wu Shun Wong (20014452), Anthony O'Sullivan (20020761)   +4 more
core  

Extracellular vesicles and their content in the context of polycystic ovarian syndrome and endometriosis: a review [PDF]

Extracellular vesicles (EVs), particles enriched in bioactive molecules like proteins, nucleic acids, and lipids, are crucial mediators of intercellular communication and play key roles in various physiological and pathological processes.
Duval, Cyntia, Librach, Clifford L., Wyse, Brandon A, Wyse, Brandon A., Tsang, Benjamin K, Librach, Clifford L, Tsang, Benjamin K.   +6 more
core   +1 more source

Bipolar disorder in women with polycystic ovarian syndrome (PCO).

Acta medica Iranica, 2014
This study was designed to determine the prevalence of bipolar disorder in women with polycystic ovarian syndrome (PCO). One hundred and ten women with definite diagnosis of PCO and one hundred and ten age-matched infertile women due to other reasons except for PCO were enrolled in this case-control study. Ten ml fasting venous blood sample obtained to
Fatemeh Davari-Tanha, Batool Hosseini Rashidi, Mahsa Ghajarzadeh, Ahmad Ali Noorbala   +3 more
openaire   +2 more sources

Ovarian stromal hypertrophy in polycystic ovary syndrome

, 1998
OBJECTIVE: To investigate the relationship between the ovarian stromal area and clinical hormonal characteristics in women with polycystic ovary syndrome (PCOS)
Colgar, U, Elter, K, Kaleli, Semih, Oral, E, Erel, CT, Akman, C   +5 more
core  

Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome [PDF]

, 2018
Introduction: Hyperandrogenism remains as one of the key features in Polycystic Ovarian Syndrome (PCOS) and can be assessed clinically or determined by biochemical assays. Hirsutism is the most common clinical manifestation of hyperandrogenism.
Razali, Nuguelis, Nadaraja, R.N. Dineshinee, Sthaneshwar, Pavai   +2 more
core  

Smoking reduces ovarian stromal blood flow in polycystic ovary syndrome patients

, 2020
Objectives: The objective of the current research is to compare hormonal, metabolic and ovarian stromal blood flow outcomes in smoking versus non-smoking polycystic ovary syndrome (PCOS ...
Ozay, Ozlen Emekci, Ozay, Ali Cenk
core   +1 more source

The Role of Depression and Anxiety in Polycystic Ovarian Syndrome

, 2021
Polycystic ovarian syndrome (PCOS) is a common metabolic disorder that manifests in women of reproductive age. This disorder is classified by hyperandrogenism and ovulatory dysfunction which causes a wide range of symptoms including – hirsutism, acne ...
Jean-Guillaume, Samantha
core   +1 more source

Effect of Glycyrrhizic Acid on Gonadotropins, Estradiol, Testosterone and Inflammatory Cytokines in Polycystic Ovarian Syndrome Rat Model

Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2017
Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders and most important cause of anovulation. High levels of inflammatory cytokines cause deterioration of polycystic ovary syndrome.
SD Sadoughi, Z Hassanzadeh
doaj  

Bipolar Disorder and Perimenopause: An Update

Bipolar Disorders, Volume 28, Issue 7, November 2026.
ABSTRACT Objectives Perimenopause has been associated with mood worsening in some individuals, including increased depressive symptoms. Yet, the link between bipolar disorder (BD) and perimenopause remains understudied. This review aimed to provide an update on recent original studies and contextualize findings within the broader literature to guide ...
Jana Radosavljevic, Deniz Bengi, Benicio N. Frey   +2 more
wiley   +1 more source

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Journal of Internal Medicine, Volume 300, Issue 5, Page 590-609, November 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund, Johanna Melin, Anju E. Joham, Terhi T. Piltonen, D. Aled Rees, Helena J. Teede   +5 more
wiley   +1 more source